Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration
Persistent oxidative stress and inflammation contribute causally to smooth muscle cell (SMC) proliferation and migration, the characteristic features of vascular proliferative diseases. Oxidatively modified low-density lipoproteins (OxLDL) elevate oxidative stress levels, inflammatory responses, and...
Saved in:
Main Authors: | Bysani Chandrasekar, Srinivas Mummidi, Vincent G. DeMarco, Yusuke Higashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2023/6112301 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RECK as a Potential Crucial Molecule for the Targeted Treatment of Sepsis
by: Qin Y, et al.
Published: (2025-02-01) -
Economic Spectrofluorometric Bioanalysis of Empagliflozin in Rats’ Plasma
by: Bassam Ayoub, et al.
Published: (2021-01-01) -
SPOCK2 controls the proliferation and function of immature pancreatic β-cells through MMP2
by: Katarzyna Blaszczyk, et al.
Published: (2025-01-01) -
Electronegative LDL: A Circulating Modified LDL with a Role in Inflammation
by: Montserrat Estruch, et al.
Published: (2013-01-01) -
Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population
by: Erik Håkansson, et al.
Published: (2021-01-01)